Form 4: Leap Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Patricia A. Martin, a Director of Leap Therapeutics, Inc., sold 50,000 shares of common stock on September 23, 2026 for $3.86 per share.
Summary
- Open-market sale: disposed of 50,000 Common Stock at $3.86 ($193,000) on September 23, 2026; holds 118,750 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $193,000 of stock on the open market.
Insider Transactions
Patricia A. Martin — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-23 | Open-market sale | Common Stock | 50,000 | $4 | $193.0K | 118,750 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-23 | Open-market sale (50,000 shares) |
Keywords
insider transaction, Form 4, CYPH, CYPHERPUNK TECHNOLOGIES INC., bearish, Patricia A. Martin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.